On the basis of these findings, we assessed whether adoptive transfer of lung tumor-infiltrating CD4+ T cells treated ex vivo with activin-A could reduce lung tumor burden and enhance the overall survival of LLC-OVA tumor-bearing mice (Fig. 3A). Here, CD4 is linked to neoplasm.